American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

CollPlant Biotechnologies Ltd (CLGN)

$0.31 +0.77% NASDAQ: CLGN · 15-min delayed

Public · NASDAQ: CLGN
39 employees

Visit website Follow

$5.4MMarket cap

$2.4MRevenue · FY2025

-$11.5MNet income

39Employees

CLGNNASDAQ

2021IPO

About CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: CLGN
Employees: 39
IPO date: Jun 4, 2021
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: CLGN Nasdaq
SEC CIK: 1631487
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies

Embed this company’s badge

Show CollPlant Biotechnologies Ltd’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/collplant-biotechnologies-ltd/"><img src="https://americancompanies.com/badge/collplant-biotechnologies-ltd.svg" alt="CollPlant Biotechnologies Ltd — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow CollPlant Biotechnologies Ltd and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $2.4M
Net income: -$11.5M
Total assets: $10.8M
Market cap: $5.4M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: CLGN

$0.31 +0.77%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.29 $3.15

52-week range

Market cap: $5.4M
Shares outstanding: 17.3M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jun 4, 2021

CollPlant Biotechnologies Ltd (CLGN) Stock Price

Reported a net loss of $11.5M in FY2025.
Trading 90% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review CollPlant Biotechnologies Ltd.

Write a review

Newsroom

News about CollPlant Biotechnologies Ltd

Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy Benzinga · 2026-05-29 · positive CollPlant Biotechnologies Launches Redesigned Corporate Website Benzinga · 2026-03-18 · neutral Global Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18% GlobeNewswire Inc. · 2024-08-22 · neutral Nurix Therapeutics (NRIX) Moves 7.7% Higher: Will This Strength Last? Zacks Investment Research · 2024-05-20 CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock? Zacks Investment Research · 2024-05-10 Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session Benzinga · 2023-06-26

News & sentiment via Polygon.io

FAQ

CollPlant Biotechnologies Ltd: frequently asked questions

Is CollPlant Biotechnologies Ltd an American company?

CollPlant Biotechnologies Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is CollPlant Biotechnologies Ltd publicly traded?

Yes — CollPlant Biotechnologies Ltd is a publicly traded company. Its stock trades under the ticker symbol CLGN on the NASDAQ.

What does CollPlant Biotechnologies Ltd do?

CollPlant Biotechnologies Ltd is an American Medical Devices company in the Health & Beauty sector.

Explore